153 related articles for article (PubMed ID: 23166633)
1. Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomas.
Chiang YJ; Difilippantonio MJ; Tessarollo L; Morse HC; Hodes RJ
PLoS One; 2012; 7(11):e49305. PubMed ID: 23166633
[TBL] [Abstract][Full Text] [Related]
2. Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.
Gostissa M; Bianco JM; Malkin DJ; Kutok JL; Rodig SJ; Morse HC; Bassing CH; Alt FW
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2934-9. PubMed ID: 23382223
[TBL] [Abstract][Full Text] [Related]
3. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
[TBL] [Abstract][Full Text] [Related]
4. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer.
Adams CM; Eischen CM
Cancer Res; 2014 Jul; 74(14):3923-34. PubMed ID: 24840646
[TBL] [Abstract][Full Text] [Related]
6. Development of thymic lymphomas in mice disrupted of Brca2 allele in the thymus.
Park PG; Lee H
Exp Mol Med; 2008 Jun; 40(3):339-44. PubMed ID: 18587272
[TBL] [Abstract][Full Text] [Related]
7. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
Yin B; Yang-Iott KS; Chao LH; Bassing CH
Blood; 2011 Jan; 117(1):175-85. PubMed ID: 20947684
[TBL] [Abstract][Full Text] [Related]
8. NRH:quinone oxidoreductase 2-deficient mice are highly susceptible to radiation-induced B-cell lymphomas.
Iskander K; Barrios RJ; Jaiswal AK
Clin Cancer Res; 2009 Mar; 15(5):1534-42. PubMed ID: 19223498
[TBL] [Abstract][Full Text] [Related]
9. Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.
Nemajerova A; Petrenko O; Trümper L; Palacios G; Moll UM
J Clin Invest; 2010 Jun; 120(6):2070-80. PubMed ID: 20484818
[TBL] [Abstract][Full Text] [Related]
10. Distinct oncogenic phenotypes in hematopoietic specific deletions of Trp53.
Palanichamy JK; Tran TM; King JK; Katzman S; Ritter AJ; Sharma G; Tso C; Contreras JR; Fernando TR; Sanford JR; Rao DS
Sci Rep; 2023 May; 13(1):7490. PubMed ID: 37160922
[TBL] [Abstract][Full Text] [Related]
11. PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.
Rybanska I; Ishaq O; Chou J; Prakash M; Bakhsheshian J; Huso DL; Franco S
Oncogene; 2013 Apr; 32(14):1761-71. PubMed ID: 22614020
[TBL] [Abstract][Full Text] [Related]
12. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.
Bassing CH; Suh H; Ferguson DO; Chua KF; Manis J; Eckersdorff M; Gleason M; Bronson R; Lee C; Alt FW
Cell; 2003 Aug; 114(3):359-70. PubMed ID: 12914700
[TBL] [Abstract][Full Text] [Related]
13. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
[TBL] [Abstract][Full Text] [Related]
14. Changes in protein expression in p53 deleted spontaneous thymic lymphomas.
Honoré B; Vorum H; Pedersen AE; Buus S; Claësson MH
Exp Cell Res; 2004 Apr; 295(1):91-101. PubMed ID: 15051493
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation.
Krummel KA; Lee CJ; Toledo F; Wahl GM
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10188-93. PubMed ID: 16006521
[TBL] [Abstract][Full Text] [Related]
16. T-cell-specific deletion of Mof blocks their differentiation and results in genomic instability in mice.
Gupta A; Hunt CR; Pandita RK; Pae J; Komal K; Singh M; Shay JW; Kumar R; Ariizumi K; Horikoshi N; Hittelman WN; Guha C; Ludwig T; Pandita TK
Mutagenesis; 2013 May; 28(3):263-70. PubMed ID: 23386701
[TBL] [Abstract][Full Text] [Related]
17. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
[TBL] [Abstract][Full Text] [Related]
19. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
Högstrand K; Grandien A
Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
Snijders AM; Liu Y; Su L; Huang Y; Mao JH
Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
